How the Oxford-AstraZeneca covid-19 vaccine was made, BMJ

This interview with Andrew Pollard, lead for the Oxford vaccine clinical trials in the UK, Brazil, and South Africa highlights how the Oxford vaccine was developed, how dosing was determined, and whether it will be effective for the new variants.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news